School of Pharmacy, King George VI Building, Newcastle University, Newcastle-upon-Tyne, UK.
School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, PO1 2DT, UK.
Res Social Adm Pharm. 2018 Nov;14(11):1027-1042. doi: 10.1016/j.sapharm.2018.01.001. Epub 2018 Jan 4.
National Health Service (NHS) 111, a medical helpline for urgent care used within the England and Scotland, receives significant numbers of patient calls yearly for a range of clinical conditions. Some are considered high acuity and mainly directed to urgent and emergency care. Low acuity conditions are also directed to these costly, overburdened services. Community pharmacy is a recognised setting for effective low acuity condition management and could offer an alternative.
To design and evaluate a new NHS111 pathway re-directing patients with low acuity conditions to community pharmacy.
Two consensus development stakeholder workshops were undertaken. A "low acuity" condition was defined as one that can be clinically assessed by a community pharmacist and requires a treatment and/or advice available within a community pharmacy. Retrospective NHS111 patient data (February-August 2016) from the North East of England and access to the NHS Pathways clinical decision support software were available to stakeholders. The NHS111 data demonstrated the volume of patient calls for these conditions that could have been redirected to community pharmacy.
Stakeholders reached consensus that 64 low acuity conditions could be safely redirected to community pharmacy via NHS111. This represented approximately 35,000 patients (11.5% of total) being shifted away from the higher cost settings in the North East region alone during February-August 2016. The stakeholder group discussions provided rationale behind their classifications of conditions to ensure patient safety, the care experience and added value.
The resulting definitive list of low acuity conditions that could be directed to community pharmacy via NHS111 could result in a shift of workload from urgent and emergency care settings. Future work needs to evaluate the cost, clinical outcomes, patient satisfaction of a community pharmacy referral service that has the potential to improve integration of community pharmacy in the wider NHS.
英国国民医疗服务体系(NHS)111 是一个用于英格兰和苏格兰紧急护理的医疗热线,每年都会收到大量的患者来电,涉及各种临床病症。其中一些被认为是高急症,主要针对紧急和急救护理。低急症也会被转至这些昂贵且负担过重的服务。社区药房是有效管理低急症的公认场所,并且可以提供替代方案。
设计并评估一条新的 NHS111 转介路径,将低急症患者转至社区药房。
进行了两次共识发展利益相关者研讨会。将“低急症”定义为可以由社区药剂师进行临床评估的病症,并且需要在社区药房提供治疗和/或可用的建议。利益相关者可以使用来自英格兰东北部的 NHS111 患者回顾性数据(2016 年 2 月至 8 月)和 NHS 路径临床决策支持软件。 NHS111 数据显示了这些病症中有多少患者可以被转介至社区药房,从而可以转至社区药房。
利益相关者达成共识,共有 64 种低急症可以通过 NHS111 安全转介至社区药房。这代表仅在 2016 年 2 月至 8 月期间,就有 35000 名患者(占总数的 11.5%)从东北部的高成本环境中转移。利益相关者小组讨论提供了他们对病症分类的理由,以确保患者安全、护理体验和附加值。
通过 NHS111 转介至社区药房的低急症的最终明确清单可能会导致从紧急和急救护理环境中转移工作量。未来的工作需要评估社区药房转介服务的成本、临床结果和患者满意度,该服务有可能改善社区药房在更广泛的 NHS 中的整合。